UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052893
Receipt number R000058825
Scientific Title Comparison of postoperative analgesia between femoral nerve block with local infiltration anesthesia and suprainguinal fascia iliaca compartment block with local infiltration anesthesia in the posterior approach to total hip arthroplasty
Date of disclosure of the study information 2023/11/24
Last modified on 2023/11/24 15:58:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of postoperative analgesia between femoral nerve block with local infiltration anesthesia and suprainguinal fascia iliaca compartment block with local infiltration anesthesia in the posterior approach to total hip arthroplasty

Acronym

Comparison of postoperative analgesia between femoral nerve block with local infiltration anesthesia and suprainguinal fascia iliaca compartment block with local infiltration anesthesia in the posterior approach to total hip arthroplasty

Scientific Title

Comparison of postoperative analgesia between femoral nerve block with local infiltration anesthesia and suprainguinal fascia iliaca compartment block with local infiltration anesthesia in the posterior approach to total hip arthroplasty

Scientific Title:Acronym

Comparison of postoperative analgesia between femoral nerve block with local infiltration anesthesia and suprainguinal fascia iliaca compartment block with local infiltration anesthesia in the posterior approach to total hip arthroplasty

Region

Japan


Condition

Condition

hip osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare the effectiveness of femoral nerve block with local infiltration analgesia and suprainguinal fascia iliaca compartment block with local infiltration analgesia for analgesia after total hip arthroplasty.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Numerical Rating Scale (NRS) immediately after surgery (0 hour), 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours

Key secondary outcomes

Nausea and vomiting at 24 hours postoperatively and frequency of rescue analgesia at 12 and 24 hours


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Femoral nerve block combined with local infiltration anesthesia or suprainguinal fascia iliaca compartment block combined with local infiltration anesthesia in patients undergoing total hip arthroplasty

Interventions/Control_2

Evaluate the degree of pain immediately after surgery, 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours after surgery.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing total hip arthroplasty who weigh 50-80 kg and ASA-PS 1-2.

Key exclusion criteria

Patients with hepatic or renal dysfunction, allergies to the subject drug, coagulopathy or systemic anticoagulation, or failure to consent to the study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name URABE
Middle name
Last name SHIGEHIKO

Organization

Nagasaki Rosai Hospital

Division name

Anesthesiology

Zip code

857-0134

Address

2-12-5 Setogoe, Sasebo, Nagasaki

TEL

0956492191

Email

shigehikourabe@yahoo.co.jp


Public contact

Name of contact person

1st name URABE
Middle name
Last name SHIGEHIKO

Organization

Nagasaki Rosai Hospital

Division name

Anesthesiology

Zip code

857-0134

Address

2-12-5 Setogoe, Sasebo, Nagasaki

TEL

09068953862

Homepage URL


Email

shigehikourabe@yahoo.co.jp


Sponsor or person

Institute

Nagasaki Rosai Hospital

Institute

Department

Personal name

URABE SHIGEHIKO


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki Rosai Hospital

Address

2-12-5 Setogoe, Sasebo, Nagasaki

Tel

0956492191

Email

shigehikourabe@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長崎労災病院


Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 24 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 05 Month 28 Day

Date of IRB

2023 Year 05 Month 29 Day

Anticipated trial start date

2023 Year 05 Month 29 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2023 Year 11 Month 24 Day

Last modified on

2023 Year 11 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058825


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name